Maxrel Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Delhi, Delhi, India, established in 2016.
2016 Delhi, Delhi, India Active
Last Updated:
Access Report
About Maxrel Pharmaceuticals Private Limited

Maxrel Pharmaceuticals Private Limited, a active private limited company, was established on 13 May 2016 in Delhi, Delhi, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds CIN: U51909DL2016PTC299619. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Dilbag Singh (Director), Sandip Garg (Director). Past directors included Sita Devi. It holds ₹2.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at # 155, Khasra No. 72/22/23 Mundka, Delhi, Delhi, 110041.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909DL2016PTC299619

  • Registration Number

    299619

  • Incorporation Date

    13 May 2016

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.00 M
  • Revenue Growth **** 33.66%
  • Profit Growth **** 67.17%
  • Ebitda **** 382.48%
  • Net Worth 138.50%
  • Total Assets **** 10.77%
Company report

Maxrel Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Maxrel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Maxrel Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dilbag Singh Director 05 Jul 2016 Current
Sandip Garg Director 13 May 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Jul 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Maxrel Pharmaceuticals.

Maxrel Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.66% increase. The company also saw a substantial improvement in profitability, with a 67.17% increase in profit. The company's net worth Soared by an impressive increase of 138.5%.

Maxrel Pharmaceuticals revenue growth over time
Maxrel Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 33.66%
*******
*******
*******
*******
Revenue from Operations
*******
 33.66%
*******
*******
*******
*******
Total Assets
*******
 10.77%
*******
*******
*******
*******
Profit or Loss
*******
 67.17%
*******
*******
*******
*******
Net Worth
*******
 138.50%
*******
*******
*******
*******
EBITDA
*******
 382.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Maxrel Pharmaceuticals?

In 2018, Maxrel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 0.20 Cr
Latest Charge Details
Date Lender Amount Status
02 Sep 2022 State Bank Of India ₹2.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Maxrel Pharmaceuticals?

Unlock and access historical data on people associated with Maxrel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maxrel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxrel Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Maxrel Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Maxrel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Maxrel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of India of Rs. 2.00 M registered on 02 Sep 2022 with Charge ID 100626291 was modified on 13 Oct 2023. was documented.

  • Charges

    The activity A charge with State Bank Of India amounted to Rs. 2.00 M with Charge ID 100626291 was registered on 02 Sep 2022. was completed.

  • Director Appointment

    Dilbag Singh was appointed as a Director was appointed as a Director on 05 Jul 2016 & has been associated with this company since 9 years 11 months . was recorded as a recent event.

  • Director Appointment

    Sandip Garg was appointed as a Director was appointed as a Director on 13 May 2016 & has been associated with this company since 10 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Maxrel Pharmaceuticals Private Limited?

The CIN of Maxrel Pharmaceuticals Private Limited is U51909DL2016PTC299619.

Where is Maxrel Pharmaceuticals Private Limited headquartered?

Maxrel Pharmaceuticals Private Limited is headquartered at # 155, Khasra No. 72/22/23 Mundka, Delhi, Delhi, 110041.

When was Maxrel Pharmaceuticals Private Limited incorporated?

Maxrel Pharmaceuticals Private Limited was incorporated on 13 May 2016.

Who are the current directors of Maxrel Pharmaceuticals Private Limited?

The current directors of Maxrel Pharmaceuticals Private Limited are

What is the primary industry of Maxrel Pharmaceuticals Private Limited?

The primary industry of Maxrel Pharmaceuticals Private Limited is Healthcare.

Is Maxrel Pharmaceuticals Private Limited a listed company?

Maxrel Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Maxrel Pharmaceuticals Private Limited?

The authorized capital of Maxrel Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Maxrel Pharmaceuticals Private Limited?

The compliance status of Maxrel Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available